0001209191-11-032949.txt : 20110603 0001209191-11-032949.hdr.sgml : 20110603 20110603163905 ACCESSION NUMBER: 0001209191-11-032949 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110517 FILED AS OF DATE: 20110603 DATE AS OF CHANGE: 20110603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BIOTECH GROWTH N V CENTRAL INDEX KEY: 0001259869 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-53173 FILM NUMBER: 11892681 MAIL ADDRESS: STREET 1: DE RUYTERKADE 62 WILLEMSTAD CITY: CURACO STATE: P8 ZIP: 000000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Radius Health, Inc. CENTRAL INDEX KEY: 0001428522 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 800145732 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ATTN: CHIEF FINANCIAL OFFICER STREET 2: 201 BROADWAY, 6TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617 425 9225 MAIL ADDRESS: STREET 1: ATTN: CHIEF FINANCIAL OFFICER STREET 2: 201 BROADWAY, 6TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: MPM ACQUISITION CORP DATE OF NAME CHANGE: 20080228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BB BIOTECH AG CENTRAL INDEX KEY: 0000924223 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-53173 FILM NUMBER: 11892680 BUSINESS ADDRESS: STREET 1: VODERGASSE 3 STREET 2: SWITZERLAND CITY: SCHAFFHAUSEN STATE: V8 ZIP: CH-8300 BUSINESS PHONE: 411724 59 59 MAIL ADDRESS: STREET 1: VODERGASSE 3 STREET 2: SWITZERLAND CITY: SCHAFFHAUSEN STATE: V8 ZIP: CH-8300 3 1 doc3.xml FORM 3 SUBMISSION X0203 3 2011-05-17 0 0001428522 Radius Health, Inc. NONE 0001259869 BIOTECH GROWTH N V SNIPWEG 26 CURACAO P8 00000 NETHERLANDS ANTILLES 0 0 1 0 0000924223 BB BIOTECH AG VORDERGASSE 3 SCHAFFHAUSEN, SWITZERLAND V8 8200 SWITZERLAND 0 0 1 0 Series A-1 Convertible Preferred Stock Common Stock 409400 D Biotech Growth N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Radius Health Inc. held directly or indirectly by Biotech Growth N.V. This Form 3 is filed jointly by BB Biotech and Biotech Growth N.V. Each share of Series A-1 Convertible Preferred Stock has no expiration date and is convertible at any time, in whole or in part, at the election of the holder at a conversion ratio of 10 shares of Common Stock for every 1 share of Preferred Stock. /s/ Michael Hutter, Signatory Authority for Biotech Growth N.V. and BB Biotech AG 2011-06-03